International Journal of Tuberculosis and Lung Disease

Aims & Scope

The International Journal of Tuberculosis and Lung Disease (IJTLD) is owned and published by The Union.

The IJTLD's main aim is the continuing education of physicians and other health personnel, and the dissemination of the most up-to-date information in the field of tuberculosis and respiratory diseases.

It publishes original articles and commissioned reviews not only on the clinical and biological aspects of pneumology, but also - and more importantly - on community aspects.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.1
2024	3.40

SJR (SCImago Journal Rank)

Year	Value
2024	0.975

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	124

Journal Rank

Year	Value
2024	5030

Journal Citation Indicator

Year	Value
2024	1013

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Global burden of asthma among children

  Citation: 525

  Authors: I., N.

• Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients

  Citation: 270

  Authors: K. J. M., A., E., M. R., P. K., M. A., H. L.

• Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review

  Citation: 258

  Authors: C. T., Z. Z., S., R., M.

• The impact of COVID-19 on TB: a review of the data

  Citation: 245

  Authors: C. F., A., T., K., R. G.

• Mechanisms of drug resistance in <I>Mycobacterium tuberculosis</I>: update 2015

  Citation: 209

  Authors: Y., W-W.

• A systematic review of risk factors for death in adults during and after tuberculosis treatment [Review article]

  Citation: 201

  Authors: C. J., S. B.

• Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis [Review article]

  Citation: 198

  Authors: A. M., A. K., A. C., A., D.

• The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries

  Citation: 192

  Authors: D. M. G., B. R., G. J., P., M. V., S., C. F., R., K., M., Z., D., R., A.

• The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review [State of the art series. Case finding/screening. Number 2 in the series]

  Citation: 189

  Authors: K., H., K., J. E., A. E., A., E. L., K., J. R.

• The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review

  Citation: 187

  Authors: S. K., C. L., T. K.

---